Long-Term Effects of Spironolactone in Peritoneal Dialysis Patients-Reference-Cited by-同舟云学术

Long-Term Effects of Spironolactone in Peritoneal Dialysis Patients

Published:2013-12-12 Issue:5 Volume:25 Page:1094-1102
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Ito Yasuhiko,Mizuno Masashi,Suzuki Yasuhiro,Tamai Hirofumi,Hiramatsu Takeyuki,Ohashi Hiroshige,Ito Isao,Kasuga Hirotake,Horie Masanobu,Maruyama Shoichi,Yuzawa Yukio,Matsubara Tatsuaki,Matsuo Seiichi

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference48 articles.

1. Left Ventricular Mass in Chronic Kidney Disease and ESRD

2. Cardiovascular risk in the peritoneal dialysis patient

3. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

4. Left ventricular mass monitoring in the follow-up of dialysis patients: Prognostic value of left ventricular hypertrophy progression

5. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study.;London;J Am Soc Nephrol,2001

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models;International Journal of Molecular Sciences;2024-08-22

2. Management of patients with heart failure and chronic kidney disease;Heart Failure Reviews;2024-07-29

3. Hypertensive Heart Disease: Mechanisms, Diagnosis and Treatment;Reviews in Cardiovascular Medicine;2024-03-06

4. Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials;European Heart Journal;2024-01-09

5. 腹膜透析患者の体液過剰;Nihon Toseki Igakkai Zasshi;2023